Post

AstraZeneca and Nona Biosciences sign agreement for monoclonal antibody

AstraZeneca has entered a worldwide licence and option agreement with Nona Biosciences for a preclinical monoclonal antibody. The deal focuses on …

EC approves Sandoz’s biosimilars for bone-related ailments

The European Commission (EC) has granted marketing authorisation for Sandoz’s biosimilars Wyost (denosumab) and Jubbonti (denosumab) for bone-related ailments. Wyost and …

Biogen enters deal to acquire HI-Bio for $1.8bn

Biogen has signed a definitive agreement to acquire clinical-stage biotechnology company Human Immunology Biosciences (HI-Bio) in a $1.8bn deal. The clinical-stage …

Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600m

Merck KGaA’s Life Science business in the US and Canada, MilliporeSigma, has entered a definitive agreement to acquire Mirus Bio …

Pharmaceutical clean room manufacturing, flooring and design 

Pharmaceutical clean room manufacturing, flooring and design: Introduction  In the highly regulated pharmaceutical industry, the creation and maintenance of clean rooms …